Clinical Trials Directory

Trials / Unknown

UnknownNCT02662530

Clinical and Kinematic Assessment for Determination of Botox® Injection Parameters in Cervical Dystonia

Comparison of Clinical and Kinematic Assessment in the Determination of Botox® Injection Parameters in Cervical Dystonia Patients

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Western University, Canada · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study investigates the use of a kinematic measurement device to quantify the abnormal head movements and postures in patients with cervical dystonia (CD) in order to individualize and optimize botulinum toxin type A (BoNT-A) injection therapy. A single sensor captures five degrees of freedom of the neck and head that distinguish which muscle(s) contribute to CD and the amount of BoNT-A to inject into these muscle(s). The efficacy, relief and improvements in social, occupation and function by injections will be investigated. The efficacy of BoNT-A therapy using either BoNT-A injection parameters from clinical-based assessments and kinematically-based assessments will be investigated in CD patients. Individuals clinically diagnosed with CD will be randomized for two treatment conditions: A) injection parameters from a kinematic assessment only, or B) injection parameters from a clinical assessment only.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum Toxin Type AA serotype of botulinum toxin type A (BoNT-A) that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25 (SNAP-25). BoNT-A's pharmacological action is to inhibit the release of acetylcholine from the neuromuscular junction. BoNT-A peripherally applied using optimal parameters by intramuscular injections solely determined either by visual/clinical or by biomechanical analysis of dystonic movements for cervical dystonia therapy in neck and shoulder muscles every 12 weeks over 30 weeks. BoNT-A dose will range from 50-300 U.

Timeline

Start date
2012-01-01
Primary completion
2020-12-01
Completion
2021-01-01
First posted
2016-01-25
Last updated
2020-06-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02662530. Inclusion in this directory is not an endorsement.